Sessions are scheduled in local time (CEST)

Displaying One Session

Berlin Hall Educational session
Date
Fri, 12.05.2023
Time
10:45 - 12:15
Room
Berlin Hall
Chairs
  • Sibylle Loibl (Neu-Isenburg, Germany)
  • Andrew Tutt (London, United Kingdom)
New comers in the early breast cancer setting: Checkpoint and PARP inhibitors

Which checkpoint inhibitor, in which biomarker sub-group and when: What is approved, what is coming and what are the trials telling us (ID 90)

Lecture Time
10:45 - 11:05
Room
Berlin Hall
Date
Fri, 12.05.2023
Time
10:45 - 12:15
Speakers
  • Sibylle Loibl (Neu-Isenburg, Germany)
Authors
  • Sibylle Loibl (Neu-Isenburg, Germany)
New comers in the early breast cancer setting: Checkpoint and PARP inhibitors

How to improve outcomes in those non-pCR after NACT+CPI (ID 91)

Lecture Time
11:05 - 11:25
Room
Berlin Hall
Date
Fri, 12.05.2023
Time
10:45 - 12:15
Speakers
  • Sheeba Irshad (London, United Kingdom)
Authors
  • Sheeba Irshad (London, United Kingdom)
New comers in the early breast cancer setting: Checkpoint and PARP inhibitors

PARP inhibition in early breast cancer: What have we learned and how can we move forward? (ID 92)

Lecture Time
11:25 - 11:45
Room
Berlin Hall
Date
Fri, 12.05.2023
Time
10:45 - 12:15
Speakers
  • Andrew Tutt (London, United Kingdom)
Authors
  • Andrew Tutt (London, United Kingdom)
New comers in the early breast cancer setting: Checkpoint and PARP inhibitors

PARP inhibitor combination strategies in early breast cancer: Rationale and results to date (ID 93)

Lecture Time
11:45 - 12:05
Room
Berlin Hall
Date
Fri, 12.05.2023
Time
10:45 - 12:15
Speakers
  • Kevin Punie (Leuven, Belgium)
Authors
  • Kevin Punie (Leuven, Belgium)
New comers in the early breast cancer setting: Checkpoint and PARP inhibitors

Q&A and discussion (ID 94)

Lecture Time
12:05 - 12:15
Room
Berlin Hall
Date
Fri, 12.05.2023
Time
10:45 - 12:15
Speakers
  • To be Announced (Barcelona, Spain)
Authors
  • To be Announced (Barcelona, Spain)